New research shows the common joint supplement glucosamine may accelerate Alzheimer's progression. People with mild cognitive impairment taking it were 25% more likely to develop dementia, and diagnosed Alzheimer's patients faced a 25% higher death risk.
The FDA approved Tzield for stage 3 Type 1 Diabetes. It significantly slowed the decrease in C-peptide levels (a marker of the body's own insulin production) by 0.13 pmol/mL. This means preserving some natural insulin function, which can make a real difference in managing the ...
A new liver perfusion technology in SA can better preserve donor livers, meaning more viable organs for transplant. This is a quiet but crucial step for the 4,000+ patients on the waiting list.
New study shows IV statins during a heart attack reduce heart muscle damage significantly. Infarct size (area of tissue death) dropped 20%, edema (swelling due to inflammation) 13% vs oral. It's amazing how precise treatments can better protect the heart.
This UCLA study brings hopeful news for early cancer risk assessment. Tracking 6000+ adults for 18 yrs, it links subtle heart changes (like increased heart muscle mass) to future cancers like breast cancer. It could mean earlier insights for patients.
🎙️ Take a Free AI-Powered English Speaking Test
app.speakfloe.com#/onboarding/...
Repeated antibiotics in early childhood are significantly linked to a higher risk of IBD later. Data shows a 59% increased risk for Crohn's disease and 23% for ulcerative colitis. This matters.
Princeton AI sees drugs changing cell structures, even a new "flower" shape in the nucleolus (a tiny cellular component). By spotting these internal shifts, we're gaining deep insights. How will this new view of cell biology transform drug discovery for diseases like Alzheimer's?
New Alzheimer's research out of ETH Zurich highlights GRK2 as a previously underappreciated driver of neurodegeneration. In mouse studies, an experimental compound, 'Compound 10,' successfully interrupted this process, reducing nerve cell loss.
scientists just found that combining KEYTRUDA and WELIREG after surgery cuts the risk of clear cell kidney cancer (ccRCC) returning or spreading by 28%. these are new types of drugs, an immune checkpoint blocker and a growth pathway inhibitor.
